Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 50

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

De novo enzymes: from computational design to mRNA display

Golynskiy, Misha V., Seelig, Burckhard · 2010 · Trends in Biotechnology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tibtech.2010.04.003

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 49

  1. Damborsky, 2009, Computational tools for designing and engineering biocatalysts, Curr. Opin. Chem. Biol., 13, 26, 10.1016/j.cbpa.2009.02.021 · DOI
  2. Marti, 2008, Computational design of biological catalysts, Chem. Soc. Rev., 37, 2634, 10.1039/b710705f · DOI
  3. Alexey, 2009, Catalytic antibodies: balancing between Dr. Jekyll and Mr. Hyde, BioEssays, 31, 1161, 10.1002/bies.200900020 · DOI
  4. Wójcik, 2008, Catalytic activity of certain antibodies as a potential tool for drug synthesis and for directed prodrug therapies, Curr. Med. Chem., 15, 1606, 10.2174/092986708784911533 · doi:10.2174/092986708784911533
  5. Pauling, 1948, Nature of forces between large molecules of biological interest, Nature, 161, 707, 10.1038/161707a0 · DOI · Paper page
  6. Pauling, 1946, Molecular architecture and biological reactions, Chem. Eng. News, 24, 1375, 10.1021/cen-v024n010.p1375 · DOI
  7. Rothlisberger, 2008, Kemp elimination catalysts by computational enzyme design, Nature, 453, 190, 10.1038/nature06879 · DOI · Paper page
  8. Jiang, 2008, De novo computational design of retro-aldol enzymes, Science, 319, 1387, 10.1126/science.1152692 · DOI · Paper page
  9. Zanghellini, 2006, New algorithms and an in silico benchmark for computational enzyme design, Protein Sci., 15, 2785, 10.1110/ps.062353106 · DOI · Paper page
  10. Lassila, 2010, Origins of catalysis by computationally designed retroaldolase enzymes, Proc. Natl. Acad. Sci. U. S. A., 107, 4937, 10.1073/pnas.0913638107 · DOI
  11. Faiella, 2009, An artificial di-iron oxo-protein with phenol oxidase activity, Nat. Chem. Biol., 5, 882, 10.1038/nchembio.257 · doi:10.1038/nchembio.257
  12. Tramontano, 1986, Catalytic antibodies, Science, 234, 1566, 10.1126/science.3787261 · DOI · Paper page
  13. Pollack, 1986, Selective chemical catalysis by an antibody, Science, 234, 1570, 10.1126/science.3787262 · DOI · Paper page
  14. Xu, 2004, Catalytic antibodies: hapten design strategies and screening methods, Bioorg. Med. Chem., 12, 5247, 10.1016/j.bmc.2004.03.077 · doi:10.1016/j.bmc.2004.03.077
  15. Cesaro-Tadic, 2003, Turnover-based in vitro selection and evolution of biocatalysts from a fully synthetic antibody library, Nat. Biotechnol., 21, 679, 10.1038/nbt828 · DOI
  16. Seelig, 2007, Selection and evolution of enzymes from a partially randomized non-catalytic scaffold, Nature, 448, 828, 10.1038/nature06032 · DOI · Paper page
  17. Roberts, 1997, RNA-peptide fusions for the in vitro selection of peptides and proteins, Proc. Natl. Acad. Sci. U. S. A., 94, 12297, 10.1073/pnas.94.23.12297 · DOI · Paper page
  18. Nemoto, 1997, In vitro virus: bonding of mRNA bearing puromycin at the 3′-terminal end to the C-terminal end of its encoded protein on the ribosome in vitro, FEBS Lett., 414, 405, 10.1016/S0014-5793(97)01026-0 · DOI · Paper page
  19. Cho, 2006, Directed evolution of ATP binding proteins from a zinc finger domain by using mRNA display, Chem. Biol., 13, 139, 10.1016/j.chembiol.2005.10.015 · DOI · Paper page
  20. Zahnd, 2007, Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target, Nat. Methods, 4, 269, 10.1038/nmeth1003 · DOI · Paper page
  21. Keefe, 2001, Functional proteins from a random-sequence library, Nature, 410, 715, 10.1038/35070613 · DOI · Paper page
  22. Kazlauskas, 2009, Finding better protein engineering strategies, Nat. Chem. Biol., 5, 526, 10.1038/nchembio0809-526 · DOI
  23. Morley, 2005, Improving enzyme properties: when are closer mutations better? Trends Biotechnol., 23, 231
  24. Khersonsky, 2010, Evolutionary optimization of computationally designed enzymes: Kemp eliminases of the KE07 series, J. Mol. Biol., 396, 1025, 10.1016/j.jmb.2009.12.031 · DOI · Paper page
  25. Miller, 2006, Directed evolution by in vitro compartmentalization, Nat. Methods, 3, 561, 10.1038/nmeth897 · DOI · Paper page
  26. Otten, 2010, Enzyme engineering for enantioselectivity: from trial-and-error to rational design?, Trends Biotechnol., 28, 46, 10.1016/j.tibtech.2009.10.001 · DOI
  27. Iyer, 2008, Enzyme stability and stabilization – aqueous and non-aqueous environment, Process Biochem., 43, 1019, 10.1016/j.procbio.2008.06.004 · DOI · Paper page
  28. Rubin-Pitel, 2006, Recent advances in biocatalysis by directed enzyme evolution, Comb. Chem. High Throughput Screen., 9, 247, 10.2174/138620706776843183 · doi:10.2174/138620706776843183
  29. Bloom, 2005, Evolving strategies for enzyme engineering, Curr. Opin. Struct. Biol., 15, 447, 10.1016/j.sbi.2005.06.004 · DOI · Paper page
  30. Wang, 2006, Mutant library construction in directed molecular evolution, Mol. Biotechnol., 34, 55, 10.1385/MB:34:1:55 · doi:10.1385/mb:34:1:55
  31. Reetz, 2007, Iterative saturation mutagenesis (ISM) for rapid directed evolution of functional enzymes, Nat. Protocols, 2, 891, 10.1038/nprot.2007.72 · DOI · Paper page
  32. Fox, 2007, Improving catalytic function by ProSAR-driven enzyme evolution, Nat. Biotechnol., 25, 338, 10.1038/nbt1286 · DOI · Paper page
  33. Daugherty, 2007, Protein engineering with bacterial display, Curr. Opin. Struct. Biol., 17, 474, 10.1016/j.sbi.2007.07.004 · doi:10.1016/j.sbi.2007.07.004
  34. Gai, 2007, Yeast surface display for protein engineering and characterization, Curr. Opin. Struct. Biol., 17, 467, 10.1016/j.sbi.2007.08.012 · DOI · Paper page
  35. Paschke, 2006, Phage display systems and their applications, Appl. Microbiol. Biotechnol., 70, 2, 10.1007/s00253-005-0270-9 · DOI · Paper page
  36. Huang, 2007, Comparison of mRNA-display-based selections using synthetic peptide and natural protein libraries, Biochemistry, 46, 10102, 10.1021/bi700220x · DOI
  37. Cho, 2000, Constructing high complexity synthetic libraries of long ORFs using in vitro selection, J. Mol. Biol., 297, 309, 10.1006/jmbi.2000.3571 · DOI
  38. Kurz, 2000, Psoralen photo-crosslinked mRNA-puromycin conjugates: a novel template for the rapid and facile preparation of mRNA-protein fusions, Nucleic Acids Res., 28, e83, 10.1093/nar/28.18.e83 · doi:10.1093/nar/28.18.e83
  39. Tabata, 2009, Rapid antibody selection by mRNA display on a microfluidic chip, Nucleic Acids Res., 37, e64, 10.1093/nar/gkp184 · doi:10.1093/nar/gkp184
  40. Liao, 2009, mRNA display design of fibronectin-based intrabodies that detect and inhibit severe acute respiratory syndrome coronavirus nucleocapsid protein, J. Biol. Chem., 284, 17512, 10.1074/jbc.M901547200 · DOI
  41. Millward, 2007, Design of cyclic peptides that bind protein surfaces with antibody-like affinity, ACS Chem. Biol., 2, 625, 10.1021/cb7001126 · DOI
  42. Takahashi, 2003, mRNA display: ligand discovery, interaction analysis and beyond, Trends Biochem. Sci., 28, 159, 10.1016/S0968-0004(03)00036-7 · DOI · Paper page
  43. Josephson, 2005, Ribosomal synthesis of unnatural peptides, J. Am. Chem. Soc., 127, 11727, 10.1021/ja0515809 · DOI · Paper page
  44. Frankel, 2003, Encodamers: unnatural peptide oligomers encoded in RNA, Chem. Biol., 10, 1043, 10.1016/j.chembiol.2003.11.004 · DOI
  45. Wentworth, 2001, Catalytic antibodies, structure and function, Cell Biochem. Biophys., 35, 63, 10.1385/CBB:35:1:63 · doi:10.1385/cbb:35:1:63
  46. Hilvert, 2000, Crictical analysis of antibody catalysis, Annu. Rev. Biochem., 69, 751, 10.1146/annurev.biochem.69.1.751 · DOI · Paper page
  47. Guofu, 1999, Broadening the aldolase catalytic antibody repertoire by combining reactive immunization and transition state theory: new enantio- and diastereoselectivities, Angew. Chem. Int. Ed., 38, 3738, 10.1002/(SICI)1521-3773(19991216)38:24<3738::AID-ANIE3738>3.0.CO;2-2 · doi:10.1002/(sici)1521-3773(19991216)38:24<3738::aid-anie3738>3.0.co;2-2
  48. Miller, 2002, Catalytic proficiency: the unusual case of OMP decarboxylase, Annu. Rev. Biochem., 71, 847, 10.1146/annurev.biochem.71.110601.135446 · DOI · Paper page
  49. Snider, 2000, The rate of spontaneous decarboxylation of amino acids, J. Am. Chem. Soc., 122, 11507, 10.1021/ja002851c · DOI

Cited by

See all 50

Metadata

Authors
Golynskiy, M. V., & Seelig, B.
Venue
Trends in Biotechnology
Publisher
Elsevier BV
Published
2010-07
Volume
28
Issue
7
Pages
340-345
ISSN
0167-7799
Cited by
50
References
1
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.